Corcept Therapeutics
Elda Tzoumaka is a seasoned professional in regulatory affairs with extensive experience spanning over two decades. Currently serving as Director Regulatory at Corcept Therapeutics since March 2013, Elda Tzoumaka has also held roles such as Associate Director of Regulatory Affairs and Regulatory Affairs Consultant within the same organization. Prior experience includes serving as Associate Director of Regulatory Affairs at NeurogesX, Inc. and as a Regulatory Affairs Professional at ALZA Corporation/Johnson & Johnson. Elda Tzoumaka began a career in pharmaceuticals as a Research Scientist at Roche Pharmaceuticals. Educational credentials consist of a Master of Science in Neuroscience/Physiology from the University of Rochester School of Medicine and Dentistry, a Master of Science in Medical Physics from the University of Surrey, and a Bachelor of Science in Physics from the University of Ioannina.
This person is not in any teams
Corcept Therapeutics
4 followers
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.